Moreover, circulating FGF21 was non-inferior to NT-pro-BNP in predicting the presence of diastolic dysfunction, as well as predicting 1-year adverse cardiac events in patients with diastolic heart failure. The gene discussed is NPPB; the disease is diastolic heart failure.